In vitro killing by a new semisynthetic echinocandin, LY-303366, was characterized using clinical isolates of fluconazole-sensitive (Y58) and -resistant (Y180) Candida albicans as well as Candida glabrata (Y7) and Candida krusei (Y171). The 24-h kill curves for Y58 and Y180 demonstrated dose-independent killing of between 1 and 2 log 10 with LY-303366 at concentrations of 0.1, 1, 10, 50, 100, and 1,000 times the MIC. Regrowth did not occur at 24 h with either C. albicans isolate at the aforementioned LY-303366 concentrations. At their MICs, LY-303366 and amphotericin B produced similar killing kinetics in cultures of Y58, Y180, Y7, and Y171, while all cultures exposed to fluconazole at its MIC demonstrated stasis or growth over 24 h.
LY-303366 is a novel semisynthetic echinocandin antifungal agent that acts as a potent noncompetitive inhibitor of (1,3)-␤-D-glucan synthase, an enzyme essential to the structural integrity of the fungal cell wall (3, 5) . LY-303366 has demonstrated excellent in vitro (7, 9, 10, 15) and in vivo (2, (12) (13) (14) (15) activity against Aspergillus species, Pneumocystis carinii, and fluconazole-sensitive and -resistant Candida species. Given the dramatic rise in Candida infections (1), the emergence of previously uncommon fungal pathogens (8) , and the therapeutic and spectral limitations of the few presently available antifungal agents (11) , the development and characterization of new antifungal agents such as LY-303366 are imperative. The purpose of this study was to characterize in vitro killing by LY-303366 by constructing 24-h kill curves for both fluconazolesensitive and -resistant Candida albicans as well as Candida glabrata and Candida krusei. In addition, the killing kinetics of LY-303366, fluconazole, and amphotericin B were compared.
(This work was presented in part at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La., 15 to 18 September 1996.) Stock solutions of LY-303366 (Lilly Research Laboratories, Indianapolis, Ind.), amphotericin B (Bristol-Myers Squibb Canada, Saint-Laurent, Quebec, Canada), and fluconazole (Pfizer Canada, Kirkland, Quebec, Canada) were prepared from standard powders with dimethyl sulfoxide as the diluent. RPMI 1640 medium (Sigma Chemical Company, St. Louis, Mo.) was used for antifungal agent susceptibility testing (6) (6) . The LY-303366 MIC end point was defined as the lowest concentration of LY-303366 that resulted in 100% inhibition of visible growth. Antifungal agent susceptibility tests were repeated in triplicate on separate occasions.
Kill curve construction began with the inoculation of 20 ml of RPMI 1640 medium with two or three Candida colonies taken from a Sabouraud dextrose agar plate. The culture was incubated with shaking for approximately 16 h at 37°C. Onemilliliter aliquots of the culture (approximately 10 7 CFU/ml) were then added to a growth control flask containing 9 ml of RPMI 1640 medium and to test flasks containing 8.9 ml of RPMI 1640 medium plus 0.1 ml of antifungal agent concentrate. LY-303366 was tested at concentrations of 0.001, 0.01, 0.1, 1, 10, 50, 100, and 1,000 times the MIC for both the fluconazole-sensitive (Y58) and -resistant (Y180) C. albicans isolates. The comparators, amphotericin B and fluconazole, were tested against all four Candida species isolates at their MICs. Initial colony counts were performed on all cultures, the antifungal agent was added, and the flasks were incubated at 37°C with shaking. Aliquots of 100 l were removed from cultures at 1, 2, 3, 4, 5, 6, 12, and 24 h, serially diluted in cold (4°C) sterile 0.85% NaCl, and plated onto Sabouraud dextrose agar. Plates were incubated at 35°C for 18 h, and numbers of viable colonies were recorded. Experiments were performed in triplicate on separate occasions. Kill curves were constructed by plotting mean log 10 CFU per milliliter versus time. Log 10 kill values for LY-303366, amphotericin B, and fluconazole, at their MICs, were calculated after 24 h of incubation with the antimicrobial agent, with a positive value indicating killing and a negative value representing growth relative to the original inoculum.
The antifungal agent MICs for isolates Y58, Y180, Y7, and Y171 are presented in Table 1 . All four isolates possessed similar susceptibilities to LY-303366 and amphotericin B, but the fluconazole susceptibilities of isolates Y180, Y7, and Y171 were significantly lower than that of isolate Y58 (Table 1) .
Kill curves for the two isolates of C. albicans, Y58 and Y180, grown in cultures supplemented with antimicrobial agent concentrations ranging from 0.001 to 1,000 times the MIC are presented in Fig. 1 . LY-303366 displayed concentration-independent killing of 1 to 2 log 10 CFU/ml for all concentrations tested between 0.1 and 1,000 times the MIC for both the fluconazole-sensitive (Y58) and -resistant (Y180) strains of C. albicans. LY-303366 at a concentration of 0.001 times the MIC did not appear to significantly affect the growth of either Y58 or Y180 (Fig. 1) . Regrowth was not seen at 24 h in cultures of either Y58 or Y180 at LY-303366 concentrations greater than or equal to 0.1 times the MIC (Fig. 1) . Figure 2 depicts fungal killing with LY-303366, amphotericin B, and fluconazole at their MICs. LY-303366 and amphotericin B killing followed similar kinetics over 24 h for both fluconazole-sensitive (Y58) and -resistant (Y180) C. albicans (Fig. 2) as well as C. glabrata (Y7) and C. krusei (Y171) (data not shown). For all four Candida isolates, LY-303366 and amphotericin B, at their MICs, each resulted in an approximately 1.5 log 10 kill which reached a maximum after 5 to 6 h of exposure, and there was no regrowth at 24 h ( Fig. 2 and data not shown). LY-303366 and amphotericin B demonstrated significantly greater killing than fluconazole against all four Candida isolates (Fig. 2 and data not shown) . At 24 h, LY-303366 and amphotericin B demonstrated similar residual inocula, while fluconazole cultures showed stasis or growth for the entire 24 h ( Table 2) . Discussion. LY-303366 is a new semisynthetic echinocandin antifungal agent which has demonstrated significant in vitro and in vivo activity against fluconazole-sensitive and -resistant Candida species, Aspergillus species, and Pneumocystis carinii (2, 7, 9, 10, (12) (13) (14) . LY-303366 demonstrated dose-independent killing of 1 to 2 log 10 against C. albicans. LY-303366 was equally active against fluconazole-susceptible and -resistant C. albicans strains. In addition, against fluconazole-sensitive and -resistant Candida species, LY-303366 demonstrated killing activity similar to that of amphotericin B and significantly greater than that of fluconazole (Fig. 2) . However, it has been previously demonstrated that amphotericin B, unlike LY-303366, results in concentration-dependent killing at concentrations greater than the MIC (4). The observation that killing by LY-303366 at 0.1 times the MIC is similar to that at the MIC and multiples thereof suggests that the definition of the LY-303366 MIC end point as no visible growth may underestimate the antifungal activity of LY-303366. Ernst and coworkers have recently published a similar report demonstrating that LY-303366 at one-eighth its MIC resulted in killing activity similar to that at the MIC in isolates of Candida species, using identical MIC end point criteria (4) . Clearly, an alternative LY-303366 MIC end point which accurately reflects the antifungal activity of this compound must be chosen. Ernst and coworkers have suggested that a clearer relationship between MIC and antifungal activity may be obtained by using antibiotic medium 3 instead of RPMI 1640 (4).
Our work suggests, as does the work of other investigators (4) , that LY-303366 has potential as a fungicidal alternative to amphotericin B in the treatment of infections with fluconazole-sensitive and -resistant Candida species. Further in vitro and in vivo characterization of LY-303366 is warranted. a Log 10 CFU killed per milliliter following 24 h of incubation with the antifungal agent was calculated as the difference between the 24-h value and that of the initial inoculum. A positive log 10 value indicates killing, while a negative log 10 value represents growth.
